Group | No./ID | Survival/days | Primary | Pulmonary | Peritoneum |
---|---|---|---|---|---|
A/Control | 1 | 42 | x | x | x |
2 | 37 | x | x/− | x | |
3 | 36 | x | x | x | |
4 | 39 | x | x | x | |
5 | 32 | x | x/− | x | |
6 | 36 | x | x | x | |
7 | 37 | x | x/− | x/− | |
8 | 31 | x | x | x | |
9 | 36 | x | x | x | |
10 | 33 | x | x | x | |
B/RFA | 1 | 84 | x | x | x |
2 | 96 | – | x | – | |
3 | 120 | – | – | – | |
4 | 118 | – | x/− | x | |
5 | 99 | x/− | X | – | |
6 | 76 | x | x | x | |
7 | 120 | x/− | - | x | |
8 | 89 | – | x/− | x | |
9 | 84 | – | – | x | |
10 | 87 | – | x | – | |
B*/RFA reexp. | 1 | 134 | – | x | – |
2 | 127 | – | x | – | |
3 | 139 | x | x | – | |
4 | 132 | – | x | – | |
5 | 134 | x | x | x | |
6 | 141 | x | x | x | |
C/CpG B | 1 | 76 | x | – | x |
2 | 66 | x | x | x | |
3 | 54 | x | x | x | |
4 | 120 | – | – | – | |
5 | 79 | x | – | x | |
6 | 84 | x | – | – | |
7 | 67 | – | x/− | x | |
8 | 70 | x | – | x | |
9 | 75 | x | – | x | |
10 | 85 | x | – | x | |
D/RFA+CpG B | 1 | 89 | x | x/− | – |
2 | 118 | – | – | – | |
3 | 120 | – | – | – | |
4 | 120 | – | – | – | |
5 | 120 | – | – | – | |
6 | 120 | – | – | – | |
7 | 118 | – | – | – | |
8 | 118 | – | – | – | |
9 | 96 | x | – | x | |
10 | 120 | – | – | – | |
D*/RFA+CpG B reexp. | 1 | 157 | – | x | – |
2 | 160 | – | – | – | |
3 | 160 | – | – | – | |
4 | 157 | x | – | – | |
5 | 160 | – | – | – | |
6 | 160 | – | x | – |
Survival times in days and results of the performed necropsies are indicated. Macroscopical finding of malignant tissue is marked as x, malignant tissue found by light microscopy without clear macroscopic evidence of malignant tissue marked as x/− and no malignant tissue marked as –.
RFA, radiofrequency ablation; Reexp., resposition.